UnknownNot Applicable

Family Lifestyles, Actions, and Risk Education Intervention: Version 2

United States762 participantsStarted 2020-04-07

Plain-language summary

The overall purpose of this study is to determine the efficacy of the Family Lifestyles, Actions, and Risk Education (FLARE) intervention in improving melanoma preventive behaviors. Parent-child dyads, consisting of survivors of melanoma and their children, will be randomly assigned to either receive the FLARE intervention or standard education. Once enrolled, each parent-child dyad will participate in this study for just over 1 year. Both conditions will receive three bi-weekly live intervention sessions (30 minutes per session) with an interventionist, and quarterly boosters via text or email.

Who can participate

Age range8 Years – 110 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Adults are eligible for this trial if they: * Are at least 18 years old AND * Have been diagnosed with melanoma at any time in their life AND * Have at least one biological child between the ages of 8-17 years who is able to participate in the trial with them. Children are eligible to participate with their parent if they: * Are between the ages of 8-17 years AND * Had at least 1 sunburn in the last 12 months AND * Have at least one biological parent with a history of melanoma who can participate in the trial with them. Exclusion Criteria: Adults and children will be excluded from participation if they: * Do not speak English OR * Are unable to participate due to developmental delay OR * Received testing for a mutation in CDKN2A/p16, including those who participated in a previous study where they received information on CDKN2A/p16.

What they're measuring

Change in Child Sunburn Occurrence Assessed Via Sun Habits Survey

Timeframe: Baseline Assessment (Wk 0), Session 3 (Wk 5-6), Post-Assessment 1 (Wk 8-11), Post-Assessment 2 (Wk 12-15), Monthly Assessment (Wk 18-41), 1-Year Follow-Up (Wk 52), Follow-Up 2 (Wk 56), Follow-Up 3 (Wk 60), Follow-Up 4 (Wk 64)

Trial details

NCT IDNCT04201223

SponsorUniversity of Utah

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-01-31

View on ClinicalTrials.gov More Melanoma trials